Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析

◆英語タイトル:Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0438
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Granules India Ltd (GRANULES) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Ibuprofen, Paracetamol, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With offices in India, the US, UK, China and Colombia, the company offers products and solutions to companies across the world. Granules also provides contract research and manufacturing services. Its key clients include leading generic and branded pharmaceutical companies. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Ltd Key Recent Developments

Nov 29,2019: Granules India announces receipt of Establishment Inspection Report (EIR) FROM US FDA
Sep 12,2019: GRANULES INDIA: Receipt of Establishment Inspection Report (EIR) from US FDA
Aug 22,2019: Granules Pharmaceuticals announces completion of U.S. FDA inspection
Jul 26,2019: Granules India’s Bonthapally facility completed US FDA inspection
Nov 14,2018: Granules Receives Two Observations from FDA Inspection for its Formulation Facility in Chantilly, US

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Granules India Ltd – Key Facts
Granules India Ltd – Key Employees
Granules India Ltd – Key Employee Biographies
Granules India Ltd – Major Products and Services
Granules India Ltd – History
Granules India Ltd – Company Statement
Granules India Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Granules India Ltd – Business Description
Business Segment: API
Overview
Performance
Business Segment: FD
Overview
Performance
Business Segment: PFI
Overview
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
Geographical Segment: PFI
Performance
Geographical Segment: Rest of the World
Performance
Granules India Ltd – SWOT Analysis
SWOT Analysis – Overview
Granules India Ltd – Strengths
Granules India Ltd – Weaknesses
Granules India Ltd – Opportunities
Granules India Ltd – Threats
Granules India Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Granules India Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 29, 2019: Granules India announces receipt of Establishment Inspection Report (EIR) FROM US FDA
Sep 12, 2019: GRANULES INDIA: Receipt of Establishment Inspection Report (EIR) from US FDA
Aug 22, 2019: Granules Pharmaceuticals announces completion of U.S. FDA inspection
Jul 26, 2019: Granules India’s Bonthapally facility completed US FDA inspection
Nov 14, 2018: Granules Receives Two Observations from FDA Inspection for its Formulation Facility in Chantilly, US
May 24, 2018: Granules India’s Total Income increases by 18% to INR 1,703 Cr
May 16, 2018: Granules India receives EIR for Jeedimetla facility at Hyderabad,Telangana
Mar 26, 2018: Granules India’s Gagillapur and Jeedimetla facilities complete US FDA inspection
Feb 28, 2018: Granules India’s Chantilly facility received EIR from USFDA
Feb 08, 2018: Granules India’s Revenue from operation increases by 14% to INR 411 Cr
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Granules India Ltd, Key Facts
Granules India Ltd, Key Employees
Granules India Ltd, Key Employee Biographies
Granules India Ltd, Major Products and Services
Granules India Ltd, History
Granules India Ltd, Subsidiaries
Granules India Ltd, Joint Venture
Granules India Ltd, Key Competitors
Granules India Ltd, Ratios based on current share price
Granules India Ltd, Annual Ratios
Granules India Ltd, Annual Ratios (Cont...1)
Granules India Ltd, Annual Ratios (Cont...2)
Granules India Ltd, Interim Ratios
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Granules India Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Granules India Ltd, Performance Chart (2015 - 2019)
Granules India Ltd, Ratio Charts
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Granules India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EuroSibEnergo Plc-エネルギー分野:企業M&A・提携分析
    Summary EuroSibEnergo PLC (EuroSibEnergo), a subsidiary of En+ Group is an energy company and producer of hydroelectric power. EuroSibEnergo generates, transmits and distributes electricity. It operations include extraction of coal, distribution and facilitating low cost operations. The company is e …
  • International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical serv …
  • Sykes Enterprises, Incorporated:企業の戦略・SWOT・財務分析
    Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • OncoResponse Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OncoResponse Inc (OncoResponse) focuses on the discovery, development and commercialization of therapeutic antibodies for the treatment of cancer. The company’s lead program includes ONCR-201, an anti-EMP2 fully-human monoclonal antibody, which is developed for female malignancies. It utiliz …
  • MMC Corp Bhd (MMCCORP):企業の財務・戦略的SWOT分析
    Summary MMC Corp Bhd (MMC) is an investment holding company which carries out mining, mineral exploration and construction services. It operates through ports and logistics, energy and utilities, engineering and industrial development divisions. The company offers containers, bulk and breakbulk, liq …
  • Endologix Inc (ELGX):企業の財務・戦略的SWOT分析
    Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Andalay Solar Inc (WEST):企業の財務・戦略的SWOT分析
    Andalay Solar Inc (WEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nuvaira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nuvaira Inc (Nuvaira), formerly Holaira Inc is an independent medical device company that strives to develop minimally invasive products for the treatment of obstructive lung diseases. It provides Lung Denervation System, a catheter-based system intended for asthma and chronic obstructive pu …
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ryosan Company, Ltd
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Copenhagen Airports AS:企業の戦略・SWOT・財務情報
    Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report Summary Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Edcon Holdings (Proprietary) Limited:企業の戦略・SWOT・財務分析
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Zensar Technologies Limited (ZENSARTECH):企業の財務・戦略的SWOT分析
    Zensar Technologies Limited (ZENSARTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Pro Petroleum Inc:企業の戦略的SWOT分析
    Pro Petroleum Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Enstar Group Ltd.:企業の戦略・SWOT・財務情報
    Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Amgen Inc (AMGN)-医療機器分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • First Mutual Holdings Limited:企業の戦略・SWOT・財務情報
    First Mutual Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary First Mutual Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aalberts Industries NV:企業のM&A・事業提携・投資動向
    Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Mitsubishi Tanabe Pharma Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Tanabe Pharma Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆